10.21
Delcath Systems Inc (DCTH) 最新ニュース
Do Options Traders Know Something About Delcath Systems Stock We Don't? - MSN
BlackRock (NASDAQ: DCTH) holds 1.73M DELCATH shares, 4.98% - Stock Titan
Implied volatility surging for Delcath Systems stock options - MSN
How Delcath Systems Inc. (DCTH) Affects Rotational Strategy Timing - Stock Traders Daily
Delcath Systems to Host First Quarter 2026 Earnings Call - BioSpace
Delcath Systems, Inc. (DCTH) Surpasses Q2 Earnings and Revenue Estimates - MSN
Delcath Systems, Inc. (NASDAQ:DCTH) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
JPMorgan Chase & Co. Decreases Position in Delcath Systems, Inc. $DCTH - MarketBeat
Delcath Systems (NASDAQ:DCTH) Stock Price Up 0.3%Time to Buy? - MarketBeat
Delcath (DCTH) Stock Adds to Position (-1.46%) 2026-04-16Stock Trading Network - Xã Thanh Hà
(DCTH) and the Role of Price-Sensitive Allocations - Stock Traders Daily
DCTH SEC FilingsDelcath Sys 10-K, 10-Q, 8-K Forms - Stock Titan
Is Delcath (DCTH) Stock Discounted Now | Price at $10.18, Up 1.34%Bearish Pattern - UBND thành phố Hải Phòng
Risk Off: Can Delcath Systems Inc expand into new markets2026 Fed Impact & Safe Entry Zone Tips - baoquankhu1.vn
Aug Decliners: What are the future prospects of Delcath Systems IncWeekly Investment Report & Weekly High Return Forecasts - baoquankhu1.vn
Delcath Systems, Inc. (NASDAQ:DCTH) Q4 2025 earnings call transcript - MSN
Implied Volatility Soars for Delcath Systems Options - Bitget
Implied Volatility Surging for Delcath Systems Stock Options - TradingView
Is Delcath Systems Inc a strong candidate for buy and holdWeekly Trade Report & Verified Technical Signals - baoquankhu1.vn
Delcath Systems (DCTH) Gains Recognition in Clinical Guidelines - GuruFocus
Delcath therapy included in European uveal melanoma guidelines By Investing.com - Investing.com Australia
Delcath Systems, Inc. Announces Inclusion of CHEMOSAT Hepatic Delivery System for Melphalan as a Recommended Liver-Directed Regional Therapy Option in the ESMO–EURACAN Clinical Practice Guidelines for Uveal Melanoma - BioSpace
Delcath therapy included in European uveal melanoma guidelines - Investing.com
Is Delcath (DCTH) Stock Safe to Buy Now | Price at $9.76, Up 1.35%Stock Ideas - Cổng thông tin điện tử tỉnh Lào Cai
Bear Alert: Is Delcath Systems Inc a strong candidate for buy and holdMarket Weekly Review & Growth Focused Stock Reports - baoquankhu1.vn
Aug Levels: Is Delcath Systems Inc a strong candidate for buy and holdShort Setup & Risk Managed Investment Entry Signals - baoquankhu1.vn
EBIT per share of Delcath Systems, Inc. – MUN:DV3R - TradingView
DCTH PE Ratio & Valuation, Is DCTH Overvalued - Intellectia AI
Stock List: Research Stocks from Around the World - GuruFocus
DV3R.SG,0P0000X679,0 (DV3R.SG) Stock Price, News, Quote & History - Yahoo! Finance Canada
Responsive Playbooks and the DCTH Inflection - Stock Traders Daily
Delcath Systems Inc. (US24661P8077.SG) Balance Sheet - Yahoo! Finance Canada
Delcath (NASDAQ: DCTH) seeks approval to expand 2020 equity incentive plan - Stock Titan
Delcath Systems to Participate at the Society of Interventional Radiology 2026 Meeting - BioSpace
[ARS] DELCATH SYSTEMS, INC. SEC Filing - Stock Titan
DV3R.SG,0P0000X679,0 (DV3R.SG) stock price, news, quote and history - Yahoo Finance UK
Delcath Systems (DCTH) Stock Analysis Report | Ratings, Financials & Performance - Benzinga Japan
Decliners Report: What are the future prospects of Delcath Systems IncProduct Launch & Risk Adjusted Swing Trade Ideas - baoquankhu1.vn
Are options traders betting on a big move in Delcath Systems stock? - MSN
Uveal Neoplasms Markets, Companies, and Investment Opportunities Analysis 2026-2030 - GlobeNewswire
Delcath Systems, Inc. (NASDAQ:DCTH) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Q3 2025 Delcath Systems Inc Earnings Call Transcript - GuruFocus
Risk Analysis: Is Delcath Systems Inc backed by strong institutional buyingForecast Cut & Daily Stock Trend Watchlist - baoquankhu1.vn
大文字化:
|
ボリューム (24 時間):